Pacific Biosciences of California Inc. (NASDAQ:PACB) is Attracting Smart Money

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Pacific Biosciences of California Inc. (NASDAQ:PACB) reported that Feinberg Larry N. has picked up 5,516,894 of common stock as of 2017-02-06.

The acquisition brings the aggregate amount owned by Feinberg Larry N. to a total of 5,516,894 representing a 5.95% stake in the company.

For those not familiar with the company, Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company’s Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. Based on its SMRT technology, the Company has introduced the PacBio RS II System. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Based on the Company’s SMRT sequencing technology, its products enable de novo genome assembly to finish genomes in order to identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms and find genes; targeted sequencing to characterize genetic variations, and deoxyribonucleic acid (DNA) base modification identification to help characterize epigenetic regulation and DNA damage.

A glance at Pacific Biosciences of California Inc. (NASDAQ:PACB)’s key stats reveals a current market capitalization of 434.67 million based on 92.60 million shares outstanding and a price at last close of $4.78 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-09-01, Phillips picked up 3,147 at a purchase price of $4.07. This brings their total holding to 187,710 as of the date of the filing.

On the sell side, the most recent transaction saw Phillips unload 20,000 shares at a sale price of $8.44. This brings their total holding to 181,449.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Pacific Biosciences of California Inc. (NASDAQ:PACB) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.